People: Neptune Technologies & Bioressources Inc (NEPT.O)

NEPT.O on Consolidated Issue listed on NASDAQ Capital Market

1.50USD
6 May 2015
Change (% chg)

$-0.02 (-1.32%)
Prev Close
$1.52
Open
$1.51
Day's High
$1.52
Day's Low
$1.50
Volume
48,752
Avg. Vol
125,412
52-wk High
$2.88
52-wk Low
$1.11

Search Stocks

Sampalis, Fotini 

Dr. Fotini Sampalis, M.D., Ph.D., is Chief Global Strategy Officer of Neptune Technologies & Bioressources Inc. Dr. Sampalis is an Oncology Surgeon, trained in Physiology at McGill University, Medicine at the University of Patras (Greece), Dermatology at Göttingen University (Germany) and Marselisborg University (Denmark), Pediatric, General and Oncology Surgery at the University of Athens (Greece), graduate training (PhD) in Surgical Research at the University of Athens and a second PhD in Epidemiology and Experimental Surgery at McGill University. She has received several international scholarships and awards for her work on the clinical implementation of retinols skin and breast cancer including the Helen Hutchison Award for geriatric medicine. Her work on Scintimammography resulted in her appointment at the International Educational Speakers Bureau, the Canadian and U.S. Faculty of Medical Speakers for Breast Imaging. As an international scholar she leads the development and implementation of innovative micro-invasive and stereotactic robotic surgical techniques for breast cancer, for which a USA and Canadian patent application has been filed. She is a member of the American Association of Naturopathic Medicine. Dr. Sampalis has published in multiple peer reviewed publications.

Basic Compensation

Total Annual Compensation, CAD Long-Term Incentive Plans, CAD All Other, CAD Fiscal Year Total, CAD
196,000 -- 50,488 356,913

Options Compensation

  Quantity Market Value
Exercisable 592,750 1,418,090.00
Unexercisable 210,250 425,098.00
Exercised 56,250 114,187.00
Search Stocks